Bli medlem
Bli medlem

Du är här


NattoPharma ASA: NATTO: 4th Quarter and Full Year 2016 earnings release

Please find attached the 4th Quarter and Full Year 2016 Earnings

Highlights for the 4th Quarter and for the Full Year are;

4th Quarter 2016

· Revenue rose by 44 % to NOK 15,9 million
· Gross Margin for the period was 46 %, up from 31 % in Q4'15
· Positive EBITDA of NOK 0,2 million
· Profit after tax was NOK 0,6 million

Full Year 2016

· Revenue rose by 66 % to NOK 52,5 million
· Gross Margin for the year was 45 %
· EBITDA coming in at NOK -9,1 million
· Loss after tax was NOK -18,2 million

A presentation will be held via webcast by CEO Daniel H. Rosenbaum and
CFO Kjetil Ramsøy at 10 am CET, Wednesday 7th February 2017, followed
by a Q&A session directly thereafter.

Please follow the below link to join the webcast;

For more information, please contact:

Kjetil Ramsøy

CFO, NattoPharma


This information is subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act.


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.